- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03074760
A Study of Acequias Contamination & Association of Infectious Diseases in Peru
March 29, 2017 updated by: BioRed LLC
A major water supply utilized in the Lambayeque region are acequias.
Acequias are irrigation canals that are utilized by the agriculture industry for the cultivation of consumables.
Utilization of contaminated water to irrigate consumables can lead to foodborne illnesses.
Contamination studies on the acequias in the Lambayeque region have not been performed to date.
The purpose of this study is to test contamination of acequias in 9 districts in Lambayeque and determine if a difference in infection rates exists in districts with contaminated acequias vs. districts without contaminated acequias for the following diseases: H. pylori, Adenovirus, Rotavirus.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
450
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Lambayeque
-
Patapo, Lambayeque, Peru
- Recruiting
- BioRed
-
Contact:
- Lozado Dominguez
-
Pimentel, Lambayeque, Peru
- Recruiting
- BioRed
-
Contact:
- Lozado Dominguez
-
Pomalca, Lambayeque, Peru
- Recruiting
- BioRed
-
Contact:
- Lozado Dominguez
-
Pucala, Lambayeque, Peru
- Recruiting
- BioRed
-
Contact:
- Lozado Dominguez
-
Tuman, Lambayeque, Peru
- Recruiting
- BioRed
-
Contact:
- Lozado Dominguez
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
There is no study population in phase I as it is focused on the districts and their corresponding acequias.
Phase II of this study will include participants 18 years of age or older who consent to participate and are from the following districts: Eten, Pomalca, Pimentel, Patapo, Pucala, Santa Rosa, Reque, Monsefu and Sana.
Description
Inclusion Criteria:
- Currently reside in one of the following districts: Eten, Pomalca, Pimentel, Patapo, Pucala, Santa Rosa, Reque, Monsefu and Sana
- 18 years of age or older
- Consent to participate
Exclusion Criteria:
- Currently taking antiviral or antimicrobial medication
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Contaminated acequias
|
Diagnostic test for the presence of the adenovirus in the population groups
Diagnostic test for the presence of the Rotavirus in the population groups
Diagnostic test for the presence of H. pylori infection in the population groups
|
|
Non-contaminated acequias
|
Diagnostic test for the presence of the adenovirus in the population groups
Diagnostic test for the presence of the Rotavirus in the population groups
Diagnostic test for the presence of H. pylori infection in the population groups
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Contamination of acequias
Time Frame: March 20th - April 1st
|
Presence of Fecal Coliforms in the acequias
|
March 20th - April 1st
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of population with infections
Time Frame: March 20th - May 1st
|
Proportion of populations with adenovirus, rotavirus and H. pylori infections
|
March 20th - May 1st
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Robert E Goode, Campbell University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 16, 2017
Primary Completion (Anticipated)
May 1, 2017
Study Completion (Anticipated)
May 1, 2017
Study Registration Dates
First Submitted
March 4, 2017
First Submitted That Met QC Criteria
March 8, 2017
First Posted (Actual)
March 9, 2017
Study Record Updates
Last Update Posted (Actual)
March 31, 2017
Last Update Submitted That Met QC Criteria
March 29, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CUIRBRG273
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Water-Related Diseases
-
Usak State HospitalCompletedHemodialysis Complication | Water Consumption | Water-Related Diseases | Water QualityTurkey (Türkiye)
-
Iberoamerican Institute of Sports Science and Human...University of GuadalajaraCompletedRunning | Physical Conditioning, HumanMexico
-
Western University, CanadaUnknownWater | Gatorade | Coconut WaterCanada
-
Faculdade de Motricidade HumanaRecruitingDehydration | HyperhydrationPortugal
-
Sri Manakula Vinayagar Medical College and HospitalUnknownDrinking Water Handling Practice | Knowledge of Water Borne Diseases | Bacteriological Quality of WaterIndia
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka Pharmaceutical Co., Ltd.CompletedHyponatremia | Inappropriate ADH Syndrome | Water Intoxication | Water-electrolyte ImbalanceGermany
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka Pharmaceutical Co., Ltd.CompletedInappropriate ADH Syndrome | Water Intoxication | Hyponatremias | Water-Electrolyte ImbalancesUnited States
-
The Aquaya InstituteUnited States Agency for International Development (USAID); The Leona M. and... and other collaboratorsRecruitingSatisfaction | Knowledge | Water Quality | Water TreatmentGhana, Kenya
-
Mode Sensors ASOslo University HospitalCompletedEdema | Fluid and Electrolyte Imbalance | OverhydrationNorway
-
Shenzhen Institutes of Advanced Technology ,Chinese...RecruitingWater Turnover | Population Water Requirements | Deuterium DilutionChina
Clinical Trials on Adenovirus
-
Binhai Hospital of Fujian Medical UniversityShanghai Yuansong Biotechnology Co., LTDRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | ImmunocompromisedUnited States
-
Tianjin Medical University Second HospitalRecruitingMalignant Pleural Mesothelioma, AdvancedChina
-
Masonic Cancer Center, University of MinnesotaRecruiting
-
Erasmus Medical CenterAmsterdam UMC, location VUmcCompletedBrain Tumor | Recurring GlioblastomaNetherlands
-
Shanghai Fengxian District Central HospitalShanghai Yuansong Biotechnology Co., LTDRecruitingMelanoma | Breast Cancer | Head and Neck Cancer | Lung Cancer | Bladder Cancer | Cervical Carcinoma | Ovarian CarcinomaChina
-
Tongji HospitalRecruiting
-
Tongji HospitalRecruitingCervical Cancer | Endometrial Cancer | Gynecologic MalignanciesChina
-
Merck Sharp & Dohme LLCCompletedOvarian Cancer | Fallopian Tube Cancer | Metastatic Cancer | Primary Peritoneal Cavity Cancer
-
First Affiliated Hospital of Wannan Medical CollegeRecruiting